ASKER Asker Healthcare Group AB (publ)

7.026USD71.25 SEK · STO-1.04%Mkt Cap: 2.72B USDP/E: 36.36

Asker Healthcare Group AB (publ) provides medical supplies, devices, and equipment and related solutions that support patient care. The company supplies and distributes fittings and equipment; veterinary equipment; surgi…

Key Statistics

Company
Market Cap2.72B USD
Enterprise Value3.33B USD
Revenue (TTM)1.84B USD
Gross Profit677.55M USD
Net Income (TTM)48.52M USD
Revenue/Share4.80 USD
Last Price7.026 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees4.9K
CountrySE
SectorHealthcare
IndustryMedical Distribution
ISINSE0024171458
Valuation
P/E (Trailing)36.36
P/E (Forward)20.91
PEG—
EV/EBITDA17.63
EV/Revenue1.81
P/S1.48
P/B3.77
EPS (TTM)0.20 USD
EPS (Forward)—
52W Range
5.54240% of range9.285
52W High9.285 USD
52W Low5.542 USD
Profitability
Gross Margin40.93%
Oper. Margin6.67%
EBITDA Margin10.29%
Profit Margin2.93%
ROE7.51%
ROA2.93%
ROIC6.71%
ROCE7.84%
Growth
Revenue Growth15.20%
Earnings Growth50.70%
Cash Flow & Leverage
Operating CF130.95M USD
CapEx (TTM)58.18M USD
FCF Margin2.57%
FCF Yield1.74%
Net Debt608.82M USD
Net Debt/EBITDA3.22
Net Debt/FCF12.89
Balance Sheet
Debt/Equity0.89
Current Ratio1.28
Quick Ratio0.74
Book Value/Sh1.88 USD
Cash/Share0.21 USD
Dividends
Fwd Div Rate0.04 USD
Trail. Div Rate0.04 USD
Div. Yield0.55%
5Y Avg Yield—
Payout Ratio19.80%
Ex-Div DateMay 8, 2026
Pay Date—
Analyst Consensus
Rating1.8 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)9.082 USD
Upside (mean)+29.3%
Target Range7.248 USD – 10.75 USD
7.248+29.3% to mean10.75
# Analysts5
Ownership
Shares Out.383.04M
Float228.00M
Insiders4.07%
Institutions86.12%
Technical
SMA 506.695 (+4.9%)
SMA 2007.181 (-2.2%)
Beta—
S&P 52W Chg12.00%
Avg Vol (30d)485.72K
Avg Vol (10d)465.63K
Technical Indicators
RSI (14)51.0
MACD0.8570
MACD Signal1.2113
MACD Hist.-0.3543
BB Upper7.537 USD
BB Middle7.153 USD
BB Lower6.769 USD
BB Width10.73%
ATR (14)0.2441 USD
Vol Ratio (20d)4.17x

About Asker Healthcare Group (STO: ASKER)

›

Asker Healthcare Group (STO: ASKER) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Medical Distribution industry, part of the Healthcare sector, and reports about 4,898 employees.

The shares were at 71.25 SEK on 20 November 2026, down 23.3% over 52 weeks. Its 52-week range is 56.20 SEK to 94.16 SEK: the price is 24.3% below the high and 26.8% above the low.

At a market capitalisation of 27.58B SEK, it trades at 36.4 times trailing earnings and 20.9 times forward earnings. The median trailing P/E of its 17 largest Medical Distribution peers is 20.3, a premium of 79% for ASKER. It pays a dividend yielding 0.55% (it pays out 20% of its earnings), against a median of 2.55% among the dividend payers in that peer group.

Asker Healthcare Group reports return on equity of 7.5%, an operating margin of 6.7% and revenue up 15.2% year over year.

Its debt exceeds its cash by 6.17B SEK, a debt-to-equity ratio of 0.89. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. 5 analysts cover the stock, with an average rating of Buy; their mean price target of 92.10 SEK is 29.3% above the current price. The next earnings report is expected on 10 February 2027.